Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Catalent and Symbiosis Pharmaceutical Services. Biologics Manufacturing Catalent, ViralClear Enter Pact for Potential COVID-19 Treatment Catalent has signed an agreement with...

Cambrex, a CDMO of small-molecule active pharmaceutical ingredients and drug products, has named Thomas Loewald as the company’s new Chief Executive Officer (CEO) and a member of the company’s Board of Directors, effective September 7, 2020. He is...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Catalent, Emergent BioSolutions, AGC Biologics, Cobra Biologics, Jacobs Engineering, and Cascade Chemistry. Chemical/Chemical API Manufacturing Cascade Chemistry To Produce...

Lonza has named Pierre-Alain Ruffieux as the company’s new Chief Executive Officer (CEO), effective November 1, 2020. He is currently Head of Global Pharma Technical Operations at Roche where leads a 12,000-member team responsible for...

The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring Catalent, Fujifilm, PolyPeptide Group, Dyadic International, and SiO2 Material Science. Chemical/Chemical API Manufacturing Novavax Selects PolyPeptide to Manufacture...

The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring AGC Biologics, Almac, and Advent Srl. Biologics Manufacturing Advent To Manufacture COVID-19 Vaccine for Oxford University Advent Srl, a CDMO providing viral vector...

The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring MilliporeSigma, CordenPharma, Oxford Biomedica, and Kindred Biosciences. Biologics Manufacturing AstraZeneca, Oxford Biomedica in Mfg Pact for COVID-19 VaccineAstraZeneca...

GlaxoSmithKline and Samsung Biologics, a contract biologics manufacturer, have entered into a $231-million, eight-year partnership under which Samsung Biologics will provide GSK with additional capacity to manufacture and supply GSK’s...

Thermo Fisher Scientific has launched its $11.5-billion takeover offer for Qiagen, a provider of molecular diagnostics and sample preparation technologies. Thermo Fisher had previously announced the proposed acquisition earlier this year (March...

The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring AGC Biologics, Thermo Fisher Scientific, and Univercells. Biologics Manufacturing AGC Biologics, Takara Bio Enter Pact for COVID-19 Vaccine Candidate AGC Biologics, a CDMO...